Sanofi (EPA:SAN)
77.85
-0.71 (-0.90%)
Aug 20, 2026, 5:25 PM CET
Sanofi Employees
Sanofi had 74,846 employees as of December 31, 2025. The number of employees decreased by 8,032 or -9.69% compared to the previous year.
Employees
74,846
Change (1Y)
-8,032
Growth (1Y)
-9.69%
Revenue / Employee
€653,595
Profits / Employee
€52,882
Market Cap
94.12B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 74,846 | -8,032 | -9.69% |
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 213,909 |
| emeis Société anonyme | 84,600 |
| Clariane SE | 70,685 |
| Eurofins Scientific SE | 65,000 |
| Ramsay Générale de Santé | 40,000 |
| bioMérieux | 15,226 |
| Sartorius Stedim Biotech | 10,477 |
| Virbac | 6,442 |
Sanofi News
- 8 days ago - Sanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley - TheFly
- 10 days ago - Sanofi facing shortages of two drugs for Pompe disease, STAT reports - TheFly
- 13 days ago - Novavax Q2 Earnings Call Highlights - Nasdaq
- 16 days ago - Sanofi's MenQuadfi Wins EC Approval For Use In Six Week Old Infants Against Meningococcal Disease - Nasdaq
- 16 days ago - Sanofi: Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease - Finanz Nachrichten
- 16 days ago - Press Release: Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease - GlobeNewsWire
- 20 days ago - Sanofi SA (SNY) Stock Down 4.5% -- Now Undervalued? GF Score: 70/100 - GuruFocus
- 20 days ago - Sanofi (SNY) Faces Stock Decline Amid CEO's Warning on Drug Pipeline Challenges - GuruFocus